Daily FNArena News - Australia

Performance fees at JO Hambro made a welcome return for Pendal Group at the end of FY20 and continued delivery of stronger net flows could be the necessary re-rating catalyst.

Heightened interest in infection prevention should be of benefit to Nanosonics in the wake of the pandemic, although rising cases in the short term create risks.

Brambles has a defensive business with a dominant global position and is now more confident in the FY21 outlook.

Ansell’s products are readily tailored to the waves of coronavirus sweeping the world so it is no surprise guidance for FY21 has already been upgraded.

Western Areas has downgraded guidance amid lower grades as its Forrestania mines come to the end of their lives. Hence, the future lies with Odysseus.

ResMed has plenty of irons in the fire, well placed to grow from increases in home health care despite the likelihood ventilator sales will decline rapidly from the peak during the pandemic.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Independent Investment Research’s October month update on developments in Australia’s listed investment trust sector, including comparative data

With consumer expenditure confined to local leisure and domestic pursuits, Super Retail was expected to do well in the first quarter. To what extent will this continue?

Lending growth, net interest margins and deferred loans were all better than expected for Bendigo and Adelaide Bank in the September quarter, boding well for the upcoming bank reporting period.